The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
8,555
Sort by:
OTC Obesity - Singapore
US$ 990.00
... likely to have a spillover effect on OTC obesity’s performance, which limited its overall growth. Euromonitor International's OTC Obesity Products in Singapore report offers a comprehensive guide to the ... books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network ...
March 2010
32 pages
OTC Obesity - USA
US$ 990.00
Sales of OTC obesity treatments declined by 2% in 2009. The switch of Alli, the first FDA ... in 37 US states in 2007 over the previous year. While overall US obesity rates appear to be stabilising, 34% of US adults aged 20 or above were obese in 2006. Euromonitor International's OTC Obesity Products in USA ...
March 2010
47 pages
Branded vs Generics Drugs in Latin America
US$ 395.00
On every border, across every frontier of Latin America, a revolution is underway. Prefaced by the ground-breaking Hatch-Waxman Act of 1984, the war for market share between generic and branded pharma...
February 2010
52 pages
Anti-Migraine Drugs: Market Research Report
US$ 3,950.00
This report analyzes the US And European markets for Anti-Migraine Drugs in US$ Million. Annual forecasts are provided for the period 2006 ... AstraZeneca Plc, Bayer AG, Ethypharm S.A., GlaxoSmithKline Plc, Meda AB, Novartis AG, and Novartis AG. Market data and analytics are derived from primary and secondary ...
February 2010
580 pages
Cold, Cough, And Sore Throat Remedies: Market Research Report
US$ 3,950.00
This report analyzes the worldwide markets for Cold, Cough, And Sore Throat Remedies in US$ Million. The report provides separate comprehensive analytics for US, Canada, Japan, Europe, and Rest of World. Annual forecasts are provided for each region for ...
February 2010
873 pages
Allergy Drugs: Market Research Report
US$ 3,950.00
... report analyzes the US Market for Allergy Drugs in US$ Million by the following types - Prescription Antihistamines, Prescription Corticosteroids, and OTC Allergy Drugs. Annual ... Healthcare, Inc., Schering-Plough Corp, Sepracor, Inc., and Vicks. Market data and analytics are derived from primary and secondary ...
February 2010
583 pages
Epigenetics: Market Research Report
US$ 4,500.00
This report analyzes the Global market for Epigenetics in US$ Million by the following Application Areas: Drug Discovery, Diagnostics, and Others. Annual ... MGI Pharma, Inc., Millipore Corporation, OncoMethylome Sciences S.A., and Orion Genomics. Market data and analytics are derived from primary and secondary ...
February 2010
361 pages
Anti-Hypertensive Drugs: Market Research Report
US$ 3,950.00
This report analyzes the worldwide markets for Anti-Hypertensive Drugs in US$ Million. The report provides separate comprehensive analytics for US, Europe and ... Company Limited, Teva Pharmaceutical Industries Limited, and The Medicines Company. Market data and analytics are derived from primary and secondary ...
February 2010
893 pages
Research Report of China Vitamin Complex Market
US$ 400.00
Vitamin complex enjoys a global market of tens of billions of dollars. For China, a nation who makes up one-fifth of the world’s population, the application amount of vitamin complex remains only one-...
December 2009
11 pages
European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries)
US$ 7,495.00
The European market, as defined in this report, encompasses Germany, France, the United Kingdom (U.K.), Italy, Spain, Benelux (Belgium, Netherlands, and Luxemburg), Scandinavia (Finland, Denmark, Sweden, and Norway), Portugal, Austria, and Switzerland. Additional products included in this report: ...
October 2009
102 pages
OTC Obesity - Venezuela
US$ 990.00
... were no OTC obesity products available in Venezuela over the review period, although the UTC market does exist. The best known obesity medicine is Xenical ... to avoid being overweight. Reductil was also available. Euromonitor International's OTC obesity in Venezuela report offers a comprehensive guide to the size and shape of the ...
August 2009
28 pages
OTC Triptans - Venezuela
US$ 990.00
OTC triptans were not available in the Venezuelan market and it is unlikely that they will be introduced as OTC in the future. Euromonitor International's OTC triptans in Venezuela report offers ... data. Why buy this report? Get a detailed picture of the OTC triptans market; Pinpoint growth sectors and identify factors driving change ...
August 2009
28 pages
Drug Delivery Markets: Oral Delivery
US$ 2,995.00
Since our last edition of this report in 2007, The oral drug delivery market is the largest segment of the drug delivery market, and there’s no sign that it is slowing down. With pharmaceutical compan...
July 2009
130 pages
Research report on anti-HBV drug market
US$ 400.00
Under the joint impact of four anti-HBV nucleoside drugs, i.e. lamivudine, adefovir dipivoxil, entecavir and Telbivudine, from 2001~2006, anti-HBV market of China’s sample hospitals in key cities grew...
July 2009
8 pages
Research report of TCM formula granules market
US$ 400.00
TCM formula granule is a kind of granular pattern (some expensive medicines can be directly cut and granulated) made of TCM decoction pieces through single extracts, concentration, drying, and granula...
July 2009
8 pages
Drug and Device Combination (2009 - 2014)
US$ 5,650.00
... of the drug device combination products. This is supported by the fact that cardiovascular applications constitute about 64% of the entire drug-device combination applications market. A future view of the drug-device combination is that these next generation products will make single component medical devices obsolete. Europe ...
July 2009
238 pages
Prescription Drugs: Market Research Report
US$ 3,950.00
This report analyzes the worldwide markets for Prescription Drugs in US$ Billion by the following therapeutic class – Oncologics/ Cancer Drugs, Lipid Regulators, Respiratory ... 2015. A five-year historic analysis is also provided for these markets. The report profiles 292 companies including many key and ...
July 2009
1810 pages
Research report on multivitamin market
US$ 350.00
With the emergence of SARS, bird flu and H1N1flu, people’s health consciousness is growing; the entire society begins to focus on the multivitamin products. And together with the rapid development of...
June 2009
7 pages
U.S. Market for Drug-Eluting and Bare Metal Stents 2009
US$ 4,495.00
In 2008, the U.S. market for drug eluting stents was valued at $1.95 billion, representing an increase of 1.6% over 2007. Overall average selling prices are predicted to decrease over the forecast period. Additional products included in this report: Bioabsorbable Stents, Bifurcated Stentsand bare-metal stents ...
May 2009
65 pages
Report on China’s Oral Contraceptive Drugs Industry
US$ 450.00
Oral contraceptive drug has two major components: progesterone and estrogen, which achieve contraception by taking effects on physiology. Through detailed data analysis, this article is to show China’...
May 2009
12 pages
Research Report of Cold Medicine Market
US$ 400.00
It is reported that cold medicine is the type occupying the largest share in the domestic drug market, whose annual market scale reaches 8 billion yuan, market sales value reaches 4.2 billion yuan, an...
May 2009
11 pages
Report on Lipid-Lowering Drugs Market
US$ 250.00
China's morbidity rate of hyperlipemia reaches above 7%, with 90 million patients, thus the lipid-lowering drugs market is a market of huge demand. This report analyzes the classification of hyperlipe...
May 2009
9 pages
Report on Antihypertensive Drug Market
US$ 550.00
It is learned that China's hypertension morbidity rate of adults is 18.8%, treatment rate is 6.1%, and it also takes on a lowering trend of age, which attracting more and more people's attention on hy...
May 2009
15 pages
Rx to OTC Switches 2009
US$ 3,500.00
The U.S. market for Rx-to-OTC Switches encompasses a wide variety of products that have been determined safe and effective as over-the-counter products.
The market is fueled by several facto...
April 2009
150 pages
Research Report of China's OTC Industry
US$ 350.00
Against the background of global financial crisis, effects of economic recession spread through all industries. However, global drug market is little affected, and OTC market maintains sustained growt...
April 2009
6 pages
Research Report of Chinese Off-patent Drug Market, 2009
US$ 1,368.00
The off-patent drugs refer to a kind of copy drug, which have the same dosage, security, strength, quality, performance and intended uses to the commercial name drugs. The legal acquirement of the off...
April 2009
50 pages
Global Alzheimer Drugs Market: An Analysis
US$ 700.00
... diagnosis and drug treatment of Alzheimer’s disease is extremely low, which represents a potential opportunity for market players. The worldwide Alzheimer disease market is led ... in market growth. The present report analyzes Alzheimer’s disease treatment and diagnosis market and discusses major drugs being ...
March 2009
25 pages
Oral Contraceptives & Condom Market: An Analysis
US$ 800.00
... called as devices. Oral contraceptives account for a major part of the contraceptives market. Condoms and oral contraceptives are the two cornerstones of the contraceptive market. Although condoms are a type of contraceptives but these ...
March 2009
28 pages
Multiple Sclerosis Treatment Market: Opportunities for Oral Drugs
US$ 800.00
... which shows bright opportunity for oral drugs in multiple sclerosis market. The injectables market is big but ... multiple sclerosis market demand and potential opportunities prevailing in the market. It gives an overview of the disease and prevalence worldwide, also covers the total market for MS treatment ...
March 2009
29 pages
Research Report on Chinese Anti-Tumor Drug Market, 2009
US$ 1,258.80
With the deterioration of natural environment and the bad eating habits, there is an increasing number in Chinese malignant tumor patients. At present, the outbreak rate of Chinese male malignant tumo...
March 2009
60 pages
Paracetamol Industry Market Research (China)
US$ 8,640.00
... Chinese goverment's lowering the export tax rebate of paracetamol in 2007, China's paracetamol exported has been affected, with little growth of ... position of paracetamol in NSAIDs now in China? What is the current situation and trends of paracetamol production in China? How has China's paracetamol import and ...
December 2008
141 pages
Research report on the drugs market of anti-senile dementia
US$ 450.00
Since 1999, China has been growing into an aging society. With the increase of aging population, incidents of senile dementia have been on the rise. According to conservative estimates, by the end of...
November 2008
11 pages
Research report on antidepressant industry in China
US$ 300.00
With the increasing threat of depression to human health, the fight against depression is becoming a major global concern, brewing unlimited business opportunities. At present, the overall size of ant...
November 2008
7 pages
Paracetamol and PAP Production Market Research (China)
US$ 12,960.00
... growing worldwide, which promotes the production of PAP, the key raw material of paracetamol. As one of main paracetamol manufacturers in the world, China's paracetamol export has constituted 30%-40% of the ...
November 2008
116 pages
Drug Delivery Technology: Revolutionizing CNS Therapies
US$ 1,020.00
Use the incisive analysis, commentary, opinions and forecasts provided in this note to:
gain an in-depth understanding of the technology landscape for invasive, minimally invasive and non-inv...
December 2007
101 pages
Synthetic Vitamin E Market Research (China)
US$ 8,640.00
The aim of this report is to provide basic understanding to the Chinese synthetic rubber industry. The report, discusses & summarizes the categories of synthetic rubber, their production situation in China from aspects of production situation in recent years, import & export, raw materials, consumption, etc.
August 2006
121 pages
Aspirin Market Research (China)
US$ 7,448.00
... consumption, manufacturers and technology. The report focuses on the bulk aspirin, but the major preparations are also introduced. In addition, the ... overview of analgesic-antipyretic industry and the position of aspirin in it are described in the beginning of this report. Future situation is ...
April 2006
112 pages
Vitamin C Production Market Research (China)
US$ 5,400.00
... . The report, discusses & summarizes the vinyl acetate situation in China from aspects of current production situation, import & export, raw materials, consumption, pricing ...
February 2006
30 pages
